The Biomarkers of Venous Thromboembolism in Cancer Patients - Aix-Marseille Université Access content directly
Journal Articles Oncologie Year : 2016

The Biomarkers of Venous Thromboembolism in Cancer Patients

Abstract

Today, the thrombosis associated with cancer is clearly established. The risk of venous thromboembolism (VTE) in cancer is dependent on clinical parameters of cancer patients and the type of tumor. Thus, the relationship between VTE and the type of cancer is complex, caused by the tumor progression, the inflammatory state, and the hemostasis. Several biomarkers had been identified to detect VTE in cancer patients. This review summarizes usual biomarkers, assessed regularly in laboratory and included in risk assessment score, and discusses new biomarkers for prediction of VTE.
No file

Dates and versions

hal-01453350 , version 1 (02-02-2017)

Identifiers

Cite

Soraya Mezouar, Roxanne Darbousset, Corinne Frere, Philippe Debourdeau, Dominique Farge-Bancel, et al.. The Biomarkers of Venous Thromboembolism in Cancer Patients. Oncologie, 2016, 18 (1), pp.17-21. ⟨10.1007/s10269-015-2579-z⟩. ⟨hal-01453350⟩

Collections

UNIV-AMU
60 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More